CA-CLICKHOUSE
25.6.2024 17:46:36 CEST | Business Wire | Press release
ClickHouse Inc, a leader in real-time analytics, announces the expansion of ClickHouse Cloud to Microsoft Azure, providing users with even more options for deploying and managing their analytics workloads. With this expansion, ClickHouse Cloud is now available on three major cloud service providers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240625765046/en/
ClickHouse Cloud is now generally available on Microsoft Azure (Graphic: Business Wire)
As organizations increasingly adopt real-time analytics databases in their interactive, data-driven customer-facing applications, as well as in their internal data warehousing and data science workflows, ClickHouse Cloud availability on Azure offers customers greater flexibility and choice. Availability of ClickHouse Cloud in Azure Marketplace allows users to use existing Azure investments and take advantage of integrations with Azure-specific services including Microsoft Power BI and Azure Event Hubs.
“Companies of all sizes trust ClickHouse to gain valuable insights from their data, across a wide variety of use cases,” says Aaron Katz, Co-founder and CEO of ClickHouse, Inc. “This announcement reiterates our vision to bring the best real-time data warehouse to our users regardless of which cloud provider they use.”
“With ClickHouse Cloud generally available on Microsoft Azure, enterprise and digital-native companies alike can take advantage of its breadth of use cases on one of the most open and flexible cloud platforms,” said Erin Chapple, corporate vice president, Azure Core Products and Design at Microsoft. “Mutual customers and partners can now benefit from real-time analytics and business intelligence solutions to gain valuable insights from their data in new ways.”
Public Beta for ClickHouse Cloud on Azure was announced at Microsoft Build in May 2024 and is seeing strong adoption across organizations looking to build real-time analytical applications on top of Azure.
"We are thrilled about the launch of ClickHouse Cloud on Microsoft Azure," said Julian LaNeve, Chief Technology Officer at Astronomer. "Our data platform handles massive volumes of real-time events, and ClickHouse has been instrumental in delivering lightning-fast analytics. With ClickHouse Cloud on Azure, we can deploy and scale effortlessly on Azure's reliable, secure, and scalable infrastructure."
“At BaxEnergy, our mission is to make renewable energy easier, more efficient, affordable, and secure," said Marco Cecconi, Head of R&D of BaxEnergy. “ClickHouse Cloud on Microsoft Azure supports us in conducting advanced analysis on large volumes of data from various renewable energy sources. By generating actionable insights, creating detailed reports, and developing custom dashboards, we empower our customers to achieve better performance and scale their operations effectively. We have been pleasantly surprised by the remarkable speed and flexibility of ClickHouse, and their team has provided us with exceptional dedicated support.”
Some additional benefits of using ClickHouse Cloud on Azure include:
Simplicity. With ClickHouse Cloud, you create your service with a single click. You don't have to worry about the operational complexity of server configurations and cluster topology, shards and replicas, managing backups and restores, durability and fault tolerance, monitoring, or alerts. It just works.
Speed and Scale. ClickHouse Cloud is designed to handle real-time analytics on top of petabyte-scale datasets. There is no need for manual sharding or data movement, as it scales automatically. Our multi-layer cache and other cloud-native performance optimizations ensure impressive query performance for a wide variety of workloads.
Security and Reliability. ClickHouse Cloud has security best practices built in by default. It is configured with network isolation and traffic encryption. ClickHouse builds are additionally hardened, tested, and validated for ClickHouse Cloud. The service is automatically replicated across multiple availability zones for high availability.
Efficiency. ClickHouse Cloud adapts itself to the changing nature of your workloads, scaling up and down as needed. ClickHouse Cloud also takes advantage of shared object storage as its primary storage, while separating compute resources. This dramatically increases flexibility and resource efficiency, delivering industry's best price/performance ratio.
Ecosystem. Easy-to-use integrations allow users to seamlessly ingest data and interface with internal and external systems. A curated set of core and partner integrations vetted to work seamlessly with ClickHouse Cloud are provided in addition to hundreds of community-built integrations. Within the Azure ecosystem, ClickHouse Cloud features turnkey integrations with Azure Event Hubs, Power BI, and Azure Blob Storage.
ClickHouse Cloud offers a 30-day trial that includes $300 free usage credits. To get started, sign up here or subscribe from Azure Marketplace.
About ClickHouse
ClickHouse is a fast, open-source columnar database management system that allows for real-time data processing and analytics. Engineered for high performance, ClickHouse Cloud delivers exceptional query speed, making it an ideal solution for handling large volumes of data. Trusted by leading companies like Lyft, Deutsche Bank and LangChain, ClickHouse Cloud enables businesses to gain critical insights and drive decision-making with its scalable, efficient, and robust data infrastructure. For more information, visit clickhouse.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240625765046/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom